Clinical Trials

Study Title:
A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab Trastuzumab and Hyaluronidase-zzfx (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Whitney Graybill, at graybill@musc.edu. Study Coordinator, Crystal Knox, at knoxc@musc.edu. Trial opened at the following institutions: Medical University of South Carolina